{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:37:29Z","timestamp":1788957449614,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ijid.2024.107323","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T17:06:07Z","timestamp":1733331967000},"page":"107323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Convalescent plasma in patients receiving rituximab or ocrelizumab for multiple sclerosis or neuromyelitis Optica spectrum disorder with Covid-19: A multicenter retrospective study"],"prefix":"10.1016","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7864-6805","authenticated-orcid":false,"given":"Tanguy","family":"Dequidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Richier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4987-1531","authenticated-orcid":false,"given":"C\u00e9line","family":"Louapre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Ader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanis","family":"Merad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lauwerier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Jacomet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Carles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Biron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Gendrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Marlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Danion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1710-2110","authenticated-orcid":false,"given":"Tristan M","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Sotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Bourdellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4524-9064","authenticated-orcid":false,"given":"Martin","family":"Martinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges Le","family":"Falher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-8274","authenticated-orcid":false,"given":"Alexis","family":"Ferre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Pilmis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Gondran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0682-9405","authenticated-orcid":false,"given":"Pierre","family":"Simeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toufik","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Ancellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5390-401X","authenticated-orcid":false,"given":"Nicolas","family":"M\u00e9l\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Camou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolaine","family":"Destremau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Sellenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Zucman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Le Mar\u00e9chal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khawla","family":"Mellouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Elodie","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9197-7305","authenticated-orcid":false,"given":"David","family":"Luque Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Mousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7980-5650","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Sommet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8772-9029","authenticated-orcid":false,"given":"Karine","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Martin-Blondel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.107323_bib0001","doi-asserted-by":"crossref","first-page":"1316\u201134","DOI":"10.1007\/s00415-021-10744-x","article-title":"Anti-CD20 therapies for multiple sclerosis: current status and future perspectives","volume":"269","author":"Margoni","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.ijid.2024.107323_bib0002","doi-asserted-by":"crossref","first-page":"e810","DOI":"10.1016\/j.clml.2021.07.004","article-title":"Resolution of one-year persisting COVID-19 pneumonia and development of immune thrombocytopenia in a follicular lymphoma patient with preceding rituximab maintenance therapy: a follow-up report and literature review of cases with prolonged infections","volume":"21","author":"Yasuda","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.ijid.2024.107323_bib0003","doi-asserted-by":"crossref","first-page":"1100\u20115","DOI":"10.1111\/bjh.17266","article-title":"Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies","volume":"192","author":"Betrains","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijid.2024.107323_bib0004","doi-asserted-by":"crossref","first-page":"1590\u2011600","DOI":"10.1056\/NEJMoa2209502","article-title":"Convalescent plasma for covid-19\u2013induced ARDS in mechanically ventilated patients","volume":"389","author":"Misset","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2024.107323_bib0005","doi-asserted-by":"crossref","first-page":"610\u20118","DOI":"10.1056\/NEJMoa2033700","article-title":"Early high-titer plasma therapy to prevent severe covid-19 in older adults","volume":"384","author":"Libster","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2024.107323_bib0006","first-page":"2049\u201159","article-title":"Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial","volume":"397","author":"Abani","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.ijid.2024.107323_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103104","article-title":"Two patients with rituximab associated low gammaglobulin levels and relapsed covid-19 infections treated with convalescent plasma","volume":"60","author":"Ormazabal V\u00e9lez","year":"2021","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.ijid.2024.107323_bib0008","doi-asserted-by":"crossref","first-page":"1025\u201134","DOI":"10.1038\/s41375-022-01511-6","article-title":"Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis","volume":"36","author":"Hueso","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.ijid.2024.107323_bib0009","doi-asserted-by":"crossref","first-page":"24\u201131","DOI":"10.1136\/jnnp-2021-326904","article-title":"Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders","volume":"93","author":"Louapre","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ijid.2024.107323_bib0010","doi-asserted-by":"crossref","first-page":"283\u201191","DOI":"10.1080\/23744235.2021.2013528","article-title":"Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases","volume":"54","author":"Ljungquist","year":"2022","journal-title":"Infect Dis"},{"key":"10.1016\/j.ijid.2024.107323_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104880","article-title":"Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors","volume":"181","author":"Gallian","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2024.107323_bib0012","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.ijid.2024.107323_bib0013","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","author":"Marshall","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107323_bib0014","first-page":"209\u201118","article-title":"Immunocompromised patients with protracted COVID-19: a review of \u201clong persisters","volume":"9","author":"Dioverti","year":"2022","journal-title":"Curr Transplant Rep"},{"issue":"11","key":"10.1016\/j.ijid.2024.107323_bib0015","doi-asserted-by":"crossref","first-page":"2032\u201140","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2024.107323_bib0016","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.3390\/ijms22168902","article-title":"Clearance of the SARS-CoV-2 virus in an immunocompromised patient mediated by convalescent plasma without b-cell recovery","volume":"22","author":"Basheer","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijid.2024.107323_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.50647","article-title":"COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review and meta-analysis","volume":"6","author":"Senefeld","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijid.2024.107323_bib0018","doi-asserted-by":"crossref","first-page":"2478\u201184","DOI":"10.1002\/eji.202149277","article-title":"Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity","volume":"51","author":"Kremer","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ijid.2024.107323_bib0019","doi-asserted-by":"crossref","first-page":"1271\u20114","DOI":"10.1093\/cid\/ciab647","article-title":"Effects of treatment of coronavirus disease 2019 with convalescent plasma in 25 B-cell\u2013depleted patients","volume":"74","author":"Gharbharan","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.107323_bib0020","doi-asserted-by":"crossref","first-page":"21249","DOI":"10.1038\/s41598-023-48145-x","article-title":"COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients","volume":"13","author":"Kasten","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2024.107323_bib0021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/diseases12020033","article-title":"A descriptive, retrospective analysis of COVID-19 passive antibody therapy and its effects on morbidity and mortality in patients receiving b-cell-depleting therapies","volume":"12","author":"Gentile","year":"2024","journal-title":"Diseases"},{"key":"10.1016\/j.ijid.2024.107323_bib0022","first-page":"1","article-title":"Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies","volume":"14","author":"Achiron","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.ijid.2024.107323_bib0023","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamainternmed.2021.0366","article-title":"Association of SARS-CoV-2 seropositive antibody test with risk of future infection","volume":"181","author":"Harvey","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ijid.2024.107323_bib0024","doi-asserted-by":"crossref","first-page":"535\u201140","DOI":"10.1038\/nrneurol.2013.98","article-title":"Uhthoff's phenomena in MS\u2014clinical features and pathophysiology","volume":"9","author":"Frohman","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ijid.2024.107323_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.763412","article-title":"COVID-19 in B cell-depleted patients after rituximab: a diagnostic and therapeutic challenge","volume":"12","author":"Furlan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2024.107323_bib0026","doi-asserted-by":"crossref","first-page":"1015\u201127","DOI":"10.1056\/NEJMoa2031893","article-title":"Convalescent plasma antibody levels and the risk of death from covid-19","volume":"384","author":"Joyner","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ijid.2024.107323_bib0027","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/bjh.18540","article-title":"Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID -19 convalescent plasma therapy","volume":"200","author":"Gachoud","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijid.2024.107323_bib0028","doi-asserted-by":"crossref","first-page":"549\u201159","DOI":"10.1111\/bjh.18450","article-title":"Antibody response and intra-host viral evolution after plasma therapy in COVID -19 patients pre-exposed or not to B-cell-depleting agents","volume":"199","author":"Gachoud","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijid.2024.107323_bib0029","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.3346\/jkms.2023.38.e175","article-title":"Within-host evolution of SARS-CoV-2 in a b-cell depleted patient with successful treatment","volume":"38","author":"Baek","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ijid.2024.107323_bib0030","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.3390\/v15112220","article-title":"Prolonged SARS-CoV-2 infection in patients receiving Anti-CD20 monoclonal antibodies: a diagnostic challenged by negative nasopharyngeal RT-PCR and successful treatment with COVID-19 high-titer convalescent plasma","volume":"15","author":"Da Silva","year":"2023","journal-title":"Viruses"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224003989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224003989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T20:39:22Z","timestamp":1741293562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224003989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"alternative-id":["S1201971224003989"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107323","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Convalescent plasma in patients receiving rituximab or ocrelizumab for multiple sclerosis or neuromyelitis Optica spectrum disorder with Covid-19: A multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107323"}}